NCT01421797View on ClinicalTrials.gov

Evaluation of Adrenal Androgens in Normal and Obese Girls After Suppression and Stimulation

NAActive, not recruitingINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

October 10, 2006

Primary Completion Date

August 27, 2024

Study Completion Date

December 31, 2024

Conditions
HyperandrogenemiaPolycystic Ovary SyndromeObesity
Interventions
DRUG

Dexamethasone

1 mg PO

DRUG

Cortrosyn

single IV bolus of 0.25 mg will be administered

Trial Locations (1)

22902

University of Virginia Center for Research in Reproduction, Charlottesville

All Listed Sponsors
collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

collaborator

University of California, San Diego

OTHER

lead

University of Virginia

OTHER

NCT01421797 - Evaluation of Adrenal Androgens in Normal and Obese Girls After Suppression and Stimulation | Biotech Hunter | Biotech Hunter